De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Pro Medicus Beheer

Beheer criteriumcontroles 4/4

De CEO Pro Medicus' is Sam Hupert, benoemd in Jan1983, heeft een ambtstermijn van 41.75 jaar. De totale jaarlijkse vergoeding van { bedraagt A$ 965.22K, bestaande uit 95.5% salaris en 4.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 24.06% van de aandelen van het bedrijf, ter waarde A$ 4.54B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 10.9 jaar en 8.4 jaar.

Belangrijke informatie

Sam Hupert

Algemeen directeur

AU$965.2k

Totale compensatie

Percentage CEO-salaris	95.5%
Dienstverband CEO	41.8yrs
Eigendom CEO	24.1%
Management gemiddelde ambtstermijn	10.9yrs
Gemiddelde ambtstermijn bestuur	8.4yrs

Recente managementupdates

Recent updates

Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention

Aug 12

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Jul 08

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

May 09

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Apr 02

Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital

Jan 25

We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease

Dec 13

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Oct 26

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Sep 14

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Jul 06

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Jun 15

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Mar 16

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Feb 23

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Oct 26

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

Aug 13

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Jul 26

Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency

May 07

Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Mar 15

This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)

Feb 20

Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Feb 18

Is Pro Medicus (ASX:PME) The Next Multi-Bagger?

Feb 01

How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?

Jan 12

Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?

Dec 28

Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment

Dec 11

Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?

Nov 26

Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?

Aug 09

What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?

Aug 09

Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?

Jul 21

How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?

Jul 03

Analyse CEO-vergoeding

Hoe is Sam Hupert's beloning veranderd ten opzichte van Pro Medicus's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$965k	AU$921k	AU$83m
Mar 31 2024	n/a	n/a	AU$76m
Dec 31 2023	n/a	n/a	AU$70m
Sep 30 2023	n/a	n/a	AU$65m
Jun 30 2023	AU$1m	AU$723k	AU$61m
Mar 31 2023	n/a	n/a	AU$56m
Dec 31 2022	n/a	n/a	AU$51m
Sep 30 2022	n/a	n/a	AU$48m
Jun 30 2022	AU$510k	AU$475k	AU$44m
Mar 31 2022	n/a	n/a	AU$41m
Dec 31 2021	n/a	n/a	AU$38m
Sep 30 2021	n/a	n/a	AU$34m
Jun 30 2021	AU$508k	AU$475k	AU$31m
Mar 31 2021	n/a	n/a	AU$28m
Dec 31 2020	n/a	n/a	AU$25m
Sep 30 2020	n/a	n/a	AU$24m
Jun 30 2020	AU$508k	AU$475k	AU$23m
Mar 31 2020	n/a	n/a	AU$23m
Dec 31 2019	n/a	n/a	AU$22m
Sep 30 2019	n/a	n/a	AU$21m
Jun 30 2019	AU$508k	AU$475k	AU$19m
Mar 31 2019	n/a	n/a	AU$17m
Dec 31 2018	n/a	n/a	AU$16m
Sep 30 2018	n/a	n/a	AU$13m
Jun 30 2018	AU$518k	AU$475k	AU$10m

Compensatie versus markt: De totale vergoeding ($USD 666.13K ) Sam } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 4.59M ).

Compensatie versus inkomsten: De vergoeding van Sam is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Sam Hupert

41.8yrs

Tenure

AU$965,221

Compensatie

Dr. Sam Aaron Hupert, M.B.B.S., MD has been the Chief Executive Officer and Managing Director at Pro Medicus Limited (alternate name: PRO Medicus Ltd.) since October 2010. Dr. Hupert serves as Member of Ad...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Sam Hupert	Co-Founder	41.8yrs	AU$965.22k	24.06% A$ 4.8b
Anthony Hall	Co-Founder	41.8yrs	AU$373.26k	24.03% A$ 4.8b
Clayton Hatch	Chief Financial Officer	12.3yrs	AU$500.77k	0.034% A$ 6.9m
Malte Westerhoff	GM of Europe & Global CTO	no data	AU$1.59m	0.099% A$ 19.9m
Brad Levin	GM of North America & Global Head of Marketing	no data	AU$401.25k	geen gegevens
Sharni Redenbach	People & Culture Director	2.3yrs	geen gegevens	geen gegevens
Sean Lambright	Global Head of Sales - Visage Imaging Inc	9.3yrs	AU$1.21m	0.17% A$ 34.3m
Teresa Gschwind	Global Head of Customer Service of Visage Imaging Inc.	no data	geen gegevens	geen gegevens
Danny English	Financial Controller & Company Secretary	9.6yrs	geen gegevens	geen gegevens

10.9yrs

Gemiddelde duur

Ervaren management: Het managementteam van PME is doorgewinterd en ervaren (gemiddelde ambtstermijn van 10.9 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Sam Hupert	Co-Founder	41.8yrs	AU$965.22k	24.06% A$ 4.8b
Anthony Hall	Co-Founder	41.8yrs	AU$373.26k	24.03% A$ 4.8b
Alice Joans Williams	Independent Non-Executive Director	3.1yrs	AU$125.00k	0.0028% A$ 560.1k
Leigh Farrell	Independent Non-Executive Director	7.1yrs	AU$125.00k	0.0041% A$ 818.0k
Peter Kempen	Chairman	16.6yrs	AU$250.00k	0.30% A$ 60.6m
Deena Shiff	Independent Non-Executive Director	4.2yrs	AU$125.00k	0.0018% A$ 370.7k
Anthony Glenning	Independent Non-Executive Director	8.4yrs	AU$125.00k	0.0091% A$ 1.8m

8.4yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van PME wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.4 jaar).

Pro Medicus Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Co-Founder recently sold AU$88m worth of stock

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Insufficient new directors

Chairman recently sold AU$3.1m worth of stock

Pro Medicus Limited, Annual General Meeting, Nov 21, 2022

Recent updates

Price target increased by 8.6% to AU$139

Pro Medicus Limited, Annual General Meeting, Nov 25, 2024

Upcoming dividend of AU$0.22 per share

Final dividend of AU$0.22 announced

New major risk - Earnings quality

Price target increased by 15% to AU$123

Full year 2024 earnings: EPS exceeds analyst expectations

Pro Medicus Limited to Report Fiscal Year 2024 Results on Aug 14, 2024

Do Pro Medicus' (ASX:PME) Earnings Warrant Your Attention?

Upcoming dividend of AU$0.18 per share

First half dividend of AU$0.18 announced

First half 2024 earnings: EPS misses analyst expectations

Pro Medicus Limited to Report First Half, 2024 Results on Feb 15, 2024

Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today

Price target increased by 8.5% to AU$78.14

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Co-Founder recently sold AU$88m worth of stock

New minor risk - Insider selling

Pro Medicus Limited, Annual General Meeting, Nov 20, 2023

Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors

Insufficient new directors

Upcoming dividend of AU$0.17 per share at 0.5% yield

Price target increased by 7.4% to AU$67.29

New major risk - Earnings quality

Price target increased by 7.6% to AU$65.64

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention

Pro Medicus Limited to Report Fiscal Year 2023 Final Results on Aug 15, 2023

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Chairman recently sold AU$3.1m worth of stock

Upcoming dividend of AU$0.13 per share at 0.4% yield

First half 2023 earnings: EPS in line with analyst expectations despite revenue beat

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2022, Payable on March 24, 2023

Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital

Pro Medicus Limited to Report First Half, 2023 Results on Feb 15, 2023

We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease

Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)

Pro Medicus Limited, Annual General Meeting, Nov 21, 2022

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Upcoming dividend of AU$0.12 per share

Full year 2022 earnings: EPS misses analyst expectations

Pro Medicus Limited Announces Fully Franked Ordinary Dividend for the Period of Twelve Months Ended June 30, 2022, Payable on September 30, 2022

Pro Medicus Limited to Report Q4, 2022 Results on Aug 18, 2022

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Upcoming dividend of AU$0.10 per share

Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital

First half 2022 earnings: EPS and revenues exceed analyst expectations

Pro Medicus Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on March 25, 2022

Pro Medicus Limited to Report First Half, 2022 Results on Feb 16, 2022

Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?

Upcoming dividend of AU$0.08 per share

Price target increased to AU$52.25

Full year 2021 earnings released: EPS AU$0.30 (vs AU$0.22 in FY 2020)

Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively

Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?

Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency

Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Co-Founder recently sold AU$46m worth of stock

This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)

First half 2021 earnings released: EPS AU$0.13 (vs AU$0.12 in 1H 2020)

Revenue and earnings miss expectations

Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

Price target raised to AU$40.82

New 90-day high: AU$43.99

Pro Medicus Limited to Report First Half, 2021 Results on Feb 17, 2021